Molbio Diagnostics Launches 940 Crore IPO on August 10

Molbio Diagnostics, a molecular diagnostics company based in Goa, will launch an initial public offering of 940 crore rupees from August 10 to August 12, 2026. The company has set a price band for the equity shares between 768 and 807 rupees.

The offering consists of a fresh issue of shares worth 200 crore rupees and an offer for sale of approximately 740 crore rupees by existing shareholders. The company intends to use the net proceeds from the fresh issue to fund capital expenditures for research and development infrastructure and to purchase plant and machinery for its units in Goa and Visakhapatnam.

Kotak Mahindra Capital, IIFL Capital Services, Jefferies India, and Motilal Oswal Investment Advisors are serving as the book-running lead managers for the IPO.